I agree with you in that I could not find fault in anything the company or mgt has done up to this date (except maybe Leo shouldn't have said anything about the pace of news or data releases).  Everything negative is strictly investors not understanding the true nature of clinical trials and the cause for delay that would be seen due to the severe critical condition of the patients.

When CTIX is ready to roll, it will be a thing of wonder.  When that day is may be a bit delayed from which many had envisioned but whose blame shouldn't be placed on mgt.